Sources: 12Gene Ontology See all sources |
Cellular components related to medulloblastoma according to GeneDecks: (show all 15)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | cytoplasm | GO:005737 | INF | TUBB3, SSTR2, SPINT2, CTNNB1, CTNNBIP1, NRBP2 | | 2 | nucleolus | GO:005730 | 12.6 | TP53, TNR, TERT, SUFU, DDX1, ERBB4 | | 3 | cytosol | GO:005829 | 12.1 | PIK3CG, XRCC4, S100A6, AXIN1, AURKA, JUN | | 4 | integral to plasma membrane | GO:005887 | 11.3 | PLAUR, NTRK3, NTRK2, NTRK1, SSTR2, PTPRC | | 5 | Axin-APC-beta-catenin-GSK3B complex | GO:034747 | 10.9 | CTNNBIP1, CTNNB1, APC, GSK3B, AXIN2, AXIN1 | | 6 | perinuclear region of cytoplasm | GO:048471 | 10.9 | HRAS, HMGB2, ERBB2, PTCH1, CTNNB1, SNCG | | 7 | neuronal cell body | GO:043025 | 10.8 | SORT1, S100B, ASCL1, GSK3B, MET, GRIA1 | | 8 | nucleoplasm | GO:005654 | 10.7 | MAPK1, NOTCH2, NGFR, WT1, EGR1, HIF1A | | 9 | extracellular region | GO:005576 | 10.5 | NTF3, SNCA, PLAUR, NOTCH1, NOTCH2, SPINT2 | | 10 | growth cone | GO:030426 | 10.3 | SNCA, TSC1, DPYSL3, CXCR4, NTRK2, OTX2 | | 11 | extracellular space | GO:005615 | 10.2 | SHH, PDGFC, PDGFA, NGF, COL1A2, SST | | 12 | protein complex | GO:043234 | 10.1 | MDM2, MMP9, CDKN2A, PAK1, BMP2, MYC | | 13 | plasma membrane | GO:005886 | 10.1 | PTGER1, PTH1R, PTGER3, PTEN, PTCH1, PTGER4 | | 14 | cell surface | GO:009986 | 9.2 | NCAM1, SFRP1, PDGFA, PDGFB, SHH, ABCB1 | | 15 | nucleus | GO:005634 | INF | IRS1, MAGEA1, MAPK3, MAPK14, MAPK1, MAP2K1 |
Biological processes related to medulloblastoma according to GeneDecks: (show top 50)
(show all 121)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | positive regulation of protein phosphorylation | GO:001934 | 12.0 | BMP2, AXIN1, AXIN2, FAM129A, MAPK3, CCND2 | | 2 | negative regulation of cell proliferation | GO:008285 | 11.9 | KLF4, REST, SFRP1, SFRP2, BTG2, BMP2 | | 3 | apoptotic process | GO:006915 | 11.6 | NBN, VIM, RAC1, BIRC5, PAWR, PAK1 | | 4 | phosphatidylinositol-mediated signaling | GO:048015 | 11.6 | PIK3CA, PIK3R1, PCNA, AURKA, CDKN1B, FOXO1 | | 5 | response to wounding | GO:009611 | 11.6 | RAC1, PAX6, MET, CASP3, TNC, SMO | | 6 | positive regulation of cell proliferation | GO:008284 | 11.5 | KIT, SFRP1, SFRP2, NBN, VIP, VIPR1 | | 7 | positive regulation of ERK1 and ERK2 cascade | GO:070374 | 11.4 | VEGFB, BMP2, KDR, CD44, FGFR2, MAPK3 | | 8 | negative regulation of canonical Wnt receptor signaling pathway | GO:090090 | 11.3 | SFRP1, SFRP2, AXIN2, FRZB, CDH2, GSK3B | | 9 | cell cycle arrest | GO:007050 | 11.2 | RB1, NBN, MYC, RASSF1, ATM, CDK6 | | 10 | cell proliferation | GO:008283 | 11.2 | PCNA, NBN, SERPINF1, NANOG, LIG4, BCAT1 | | 11 | response to DNA damage stimulus | GO:006974 | 11.2 | BTG2, MYC, RASSF1, BCL2, YAP1, ATM | | 12 | heart development | GO:007507 | 11.1 | PCNA, VCAN, BMP2, ATM, MEF2A, MAP2K5 | | 13 | nerve growth factor receptor signaling pathway | GO:048011 | 11.1 | PIK3CA, PIK3R1, RAC1, YWHAE, CDKN1B, FOXO1 | | 14 | negative regulation of neuron differentiation | GO:045665 | 11.1 | REST, NBN, BMP7, PAX6, ITGB1, ASCL1 | | 15 | positive regulation of cell division | GO:051781 | 11.0 | VEGFB, FGF6, FGFR2, APC, IGF2, PDGFA | | 16 | virus-host interaction | GO:019048 | 10.9 | PIK3R1, BTRC, RB1, RBL1, VIM, KDR | | 17 | negative regulation of smoothened signaling pathway | GO:045879 | 10.9 | BTRC, RB1, KCTD11, GLI3, PTCH1, PTCH2 | | 18 | activation of cysteine-type endopeptidase activity involved in apoptotic process | GO:006919 | 10.9 | MYC, MOAP1, CDKN1B, CDKN2A, FASLG, FAS | | 19 | epithelial to mesenchymal transition | GO:001837 | 10.9 | BMP2, BMP7, S100A4, GSK3B, CTNNB1, NOTCH1 | | 20 | response to estradiol stimulus | GO:032355 | 10.9 | AURKA, MMP9, ENO2, CCND2, F3, CASP8 | | 21 | positive regulation of epithelial cell proliferation | GO:050679 | 10.8 | SFRP1, MYC, FGFR2, MAP2K5, CCND2, HRAS | | 22 | fibroblast growth factor receptor signaling pathway | GO:008543 | 10.8 | PIK3CA, PIK3R1, CDKN1B, FOXO1, GSK3B, FGF6 | | 23 | positive regulation of peptidyl-serine phosphorylation | GO:033138 | 10.8 | PIK3CA, SFRP2, LIF, PAK1, BCL2, AXIN1 | | 24 | protein autophosphorylation | GO:046777 | 10.8 | KIT, PAK1, KDR, AURKA, ATM, FGFR2 | | 25 | positive regulation of neuroblast proliferation | GO:002052 | 10.8 | PAX6, ASPM, GLI3, CTNNB1, NOTCH1, SHH | | 26 | signal transduction | GO:007165 | 10.7 | PIK3CD, KIT, BTRC, VIPR2, CHRND, S100A6 | | 27 | negative regulation of epithelial cell proliferation | GO:050680 | 10.7 | SFRP1, SFRP2, RB1, PAX6, CDK6, CDKN2B | | 28 | regulation of gene expression | GO:010468 | 10.7 | NANOG, BMI1, CDK6, CDK4, IRS1, NGFR | | 29 | positive regulation of MAPK cascade | GO:043410 | 10.7 | KIT, LIF, KDR, CD36, CDH2, ITGB1 | | 30 | anti-apoptosis | GO:006916 | 10.6 | PIK3CA, VEGFB, BIRC5, BCL2, BCL2L1, MUC1 | | 31 | positive regulation of fibroblast proliferation | GO:048146 | 10.6 | MYC, BMI1, LIG4, XRCC4, S100A6, JUN | | 32 | negative regulation of neuron apoptotic process | GO:043524 | 10.6 | SET, VEGFB, LIG4, BCL2, BCL2L1, BARHL1 | | 33 | induction of apoptosis by intracellular signals | GO:008629 | 10.6 | MYC, BCL2, BCL2L1, CDKN1A, CASP7, CASP3 | | 34 | positive regulation of phosphatidylinositol 3-kinase cascade | GO:014068 | 10.6 | KIT, KDR, INS, ERBB3, NTRK2, PDGFA | | 35 | Ras protein signal transduction | GO:007265 | 10.5 | RB1, RASSF1, CDKN1A, CDKN2A, MAP2K2, MAPK3 | | 36 | response to organic cyclic compound | GO:014070 | 10.5 | SFRP1, BTG2, JUN, CDKN1A, MET, ENO2 | | 37 | axon guidance | GO:007411 | 10.4 | NCAM1, RAC1, PAK1, PAX6, ITGA9, ITGAV | | 38 | positive regulation of neuron apoptotic process | GO:043525 | 10.4 | ATM, JUN, ASCL1, FASLG, CASP7, CASP3 | | 39 | positive regulation of apoptotic process | GO:043065 | 10.4 | REST, SFRP1, SFRP2, BMP2, PAWR, ATM | | 40 | positive regulation of cell migration | GO:030335 | 10.3 | BMP2, KDR, ITGAV, ITGB1, IRS1, INS | | 41 | activation of MAPK activity | GO:000187 | 10.2 | KIT, MET, GRM4, MAP2K2, MAPK3, MAPK14 | | 42 | response to drug | GO:042493 | 10.2 | SFRP1, SFRP2, NBN, MYC, BCL2, KCNK3 | | 43 | negative regulation of apoptotic process | GO:043066 | 10.1 | PIK3CG, SFRP1, PCGF2, BTG2, MYC, KDR | | 44 | positive regulation of DNA replication | GO:045740 | 10.1 | JUN, INS, MET, IGF1R, GLI1, GLI2 | | 45 | release of cytochrome c from mitochondria | GO:001836 | 10.0 | MYC, BCL2, BCL2L1, JUN, CASP7, CASP3 | | 46 | epidermal growth factor receptor signaling pathway | GO:007173 | 9.8 | PIK3CA, PIK3R1, CDKN1B, FOXO1, GSK3B, MDM2 | | 47 | negative regulation of transcription from RNA polymerase II promoter | GO:000122 | INF | KLF4, REST, PCGF2, MYC, MYB, BMI1 | | 48 | positive regulation of transcription, DNA-dependent | GO:045893 | INF | KLF4, REST, SFRP1, BTRC, RB1, MYC | | 49 | positive regulation of transcription from RNA polymerase II promoter | GO:045944 | INF | KLF4, SFRP2, RB1, RBM14, RBL1, NANOG | | 50 | negative regulation of transcription, DNA-dependent | GO:045892 | INF | KLF4, REST, SFRP1, SFRP2, BTRC, RB1 |
Molecular functions related to medulloblastoma according to GeneDecks: (show all 21)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | sequence-specific DNA binding transcription factor activity | GO:003700 | 12.4 | HIC1, EGR1, WT1, NOTCH1, CREBZF, CREBBP | | 2 | protein homodimerization activity | GO:042803 | 11.6 | SLIT2, ERBB4, ERBB3, HMGCR, CADM1, ALDH9A1 | | 3 | protein kinase binding | GO:019901 | 11.3 | CCND1, CCND2, CCNB1, MAPT, APC, TP53 | | 4 | transcription regulatory region DNA binding | GO:044212 | 11.1 | WT1, HIF1A, AHR, THRA, TFAP2A, STAT3 | | 5 | growth factor activity | GO:008083 | 11.1 | PDGFB, PDGFC, EGF, TGFA, TGFB2, DKK1 | | 6 | sequence-specific DNA binding | GO:043565 | 11.1 | HIC1, EGR1, WT1, CREBZF, PPARA, OTX2 | | 7 | protein heterodimerization activity | GO:046982 | 11.1 | TP53, OTX2, PDGFA, PDGFB, EGFR, HIF1A | | 8 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive | GO:001077 | 11.1 | HIF1A, TFAP2A, SOX11, SOX4, SOX9, WT1 | | 9 | identical protein binding | GO:042802 | 11.1 | TP73, TP53, ERBB2, AKT1, CASP8, DAZL | | 10 | beta-catenin binding | GO:008013 | 11.0 | SOX9, CTNNBIP1, SUFU, GLI3, APC, MET | | 11 | transcription factor binding | GO:008134 | 11.0 | TNFRSF10A, SUFU, CTNNB1, CREBBP, HIF1A, AHR | | 12 | protein C-terminus binding | GO:008022 | 10.6 | HRAS, ERBB2, ERCC4, CTNNB1, TOP2A, CADM1 | | 13 | transmembrane receptor protein tyrosine kinase activity | GO:004714 | 10.6 | EGFR, PDGFRA, NTRK3, NTRK1, ERBB2, ERBB4 | | 14 | protein tyrosine kinase activity | GO:004713 | 10.5 | ERBB3, ERBB4, ERBB2, PDGFRB, EGFR, IGF1R | | 15 | cyclin-dependent protein kinase inhibitor activity | GO:004861 | 10.4 | CASP3, CDKN2A, CDKN1B, CDKN2B, CDKN2C, CDKN1A | | 16 | histone deacetylase binding | GO:042826 | 10.1 | HDAC9, HDAC3, TOP2B, TOP2A, HIF1A, HIC1 | | 17 | enzyme binding | GO:019899 | 9.9 | PTEN, PTGS2, CTNNB1, PLAUR, NOTCH1, EGFR | | 18 | double-stranded DNA binding | GO:003690 | 9.8 | WT1, EGFR, EGR1, POU3F4, CTNNB1, HMGB2 | | 19 | protein binding | GO:005515 | INF | DKK1, ABCB1, EGR1, EGFR, EGF, SHH | | 20 | ATP binding | GO:005524 | INF | DAPK3, DAPK1, DDX1, TBK1, TP53, ERBB2 | | 21 | chromatin binding | GO:003682 | INF | TOP2A, TOP1, H2AFY, , TOP2B, TGIF1 |
|